MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors

MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases

(2014) E Nagy et al.   BRITISH JOURNAL OF CANCER

Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer

(2013) A. Amatu et al.   CLINICAL CANCER RESEARCH

Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma

(2013) Matthias Preusser et al.   CLINICAL NEUROPATHOLOGY

A Phase II Study of Temozolomide in Patients with Advanced Aerodigestive Tract and Colorectal Cancers and Methylation of the O6-Methylguanine-DNA Methyltransferase Promoter

(2013) D. Hochhauser et al.   MOLECULAR CANCER THERAPEUTICS

Methylation of O 6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients

(2012) Caterina Fumagalli et al.   BREAST CANCER RESEARCH AND TREATMENT

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 g

(2012) Véronique Quillien et al.   CANCER

Methylation of the Polycomb Group Target Genes Is a Possible Biomarker for Favorable Prognosis in Colorectal Cancer

(2012) A. Dallol et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Brain metastases from gastrointestinal tumours: Tailoring the approach to maximize the outcome

(2012) Jessica Menis et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Distinct Profiles of Epigenetic Evolution between Colorectal Cancers with and without Metastasis

(2011) Hai-xing Ju et al.   AMERICAN JOURNAL OF PATHOLOGY

Response to Temozolomide in Patients With Metastatic Colorectal Cancer With Loss of MGMT Expression: A New Approach in the Era of Personalized Medicine?

(2011) Einat Shacham-Shmueli et al.   JOURNAL OF CLINICAL ONCOLOGY

DNA Methylation Profiles of Primary Colorectal Carcinoma and Matched Liver Metastasis

(2011) Kazuo Konishi et al.   PLoS One

Promoter Methylation of Specific Genes is Associated with the Phenotype and Progression of Colorectal Adenocarcinomas

(2010) Jin C. Kim et al.   ANNALS OF SURGICAL ONCOLOGY

MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers

(2010) Kaori Shima et al.   CANCER CAUSES & CONTROL

Determination of the methylation status of MGMT in different regions within glioblastoma multiforme

(2010) Mark G. Hamilton et al.   JOURNAL OF NEURO-ONCOLOGY

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

(2009) J Dunn et al.   BRITISH JOURNAL OF CANCER

Concordant DNA Methylation in Synchronous Colorectal Carcinomas

(2009) K. Konishi et al.   Cancer Prevention Research

Epigenetic Deregulation of DNA Repair and Its Potential for Therapy

(2009) M. E. Hegi et al.   CLINICAL CANCER RESEARCH

Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases

(2008) Giuseppe Aprile et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY